[Endoscopic Nd-YAG laser treatment and adjuvant therapy of metastatic lesions of airway].
Endoscopic Nd-YAG laser treatment and adjuvant therapy were performed in 44 cases with metastatic lesions of airway. The best results were obtained in 31 cases (93.9%) out of 33 cases complaining of ventilatory disturbance in which endoscopic Nd-YAG laser treatment was indicated as an emergency procedure. In most of these cases with metastatic lesions of airway consisted of respiratory tract invasion from mediastinal lymph nodes in cases of esophageal cancer or lung cancer. In these cases, after laser treatment for ventilatory disturbance, the patients condition improved to the extent that adjuvant therapy could be performed. Adjuvant therapy was performed in 38 cases, there were 7 cases treated surgically (resection of the metastatic lesions of airway in 3 cases, tracheal tube stent operation in 4 cases 0, 28 radiotherapy in 28 cases (Linac irradiation in 24 cases, 60Co intraluminal irradiation of the trachea in 4 cases 0, and 32 cases were treated with chemotherapy. Tracheal tube stent operation was useful for maintenance of the tracheal lumen following laser treatment, and 60Co intraluminal irradiation was effective for the residual intratracheal tumor. The 1-year survival rate of 44 cases with metastatic lesions of airway was 42% and the 2-year survival rate was 22%, so this result suggested endoscopic Nd-YAG laser treatment and adjuvant therapy for metastatic lesions of airway was useful to prolong survival time. However the main value of this modality is for the rapid relief of severe ventilatory disturbance due to obstructive airway lesions.
Okitsu
H
H
Oho
K
K
Naitoh
J
J
Tajika
E
E
Amemiya
R
R
Hayata
Y
Y
D001984:Bronchial Neoplasms / Q000532:radiotherapy* / Q000556:secondary; D001999:Bronchoscopy; D003131:Combined Modality Therapy; D004938:Esophageal Neoplasms; D006801:Humans; D053685:Laser Therapy; D008175:Lung Neoplasms; D009361:Neoplasm Invasiveness; D011379:Prognosis; D014134:Tracheal Neoplasms / Q000532:radiotherapy* / Q000556:secondary